
NU professor is developing a medicine for malignant cancer based on vitamin C and arsenic
Dos Sarbassov, a Kazakh-American biologist and NU scientist, is completing the development of a drug that will make mutated cancer cells self-destruct. His drug, along with an American drug based on arsenic in low doses, has been shown to be effective against KRAS-mutant cells, which are found in 95%of pancreatic cancers, 30%of colon cancers, and 20%of lung cancers.








